These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8249432)

  • 41. Efficacy evaluation of two synthetic lysine lipidated tripeptides as vaccine adjuvants against HBsAg.
    Sidiq T; Khajuria A; Shafi S; Ismail T; Sampath Kumar H; Kannappa Srinivas V; Krishna E; Kamal Johri R
    Eur J Pharmacol; 2013 Apr; 705(1-3):68-78. PubMed ID: 23474022
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Impairment by mucosal adjuvants and cross-reactivity with variant peptides of the mucosal immunity induced by injection of the fusion peptide PADRE-ELDKWA.
    Decroix N; Pamonsinlapatham P; Quan CP; Bouvet JP
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1103-8. PubMed ID: 14607874
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Enhanced type I immune response to a hepatitis B DNA vaccine by formulation with calcium- or aluminum phosphate.
    Wang S; Liu X; Fisher K; Smith JG; Chen F; Tobery TW; Ulmer JB; Evans RK; Caulfield MJ
    Vaccine; 2000 Jan; 18(13):1227-35. PubMed ID: 10649624
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Bactericidal activity of antibodies elicited against the Neisseria meningitidis 37-kDa ferric binding protein (FbpA) with different adjuvants.
    Gómez JA; Criado MT; Ferreirós CM
    FEMS Immunol Med Microbiol; 1998 Jan; 20(1):79-86. PubMed ID: 9514578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of several adjuvants on the immune response against a recombinant meningococcal high molecular weight antigen.
    González S; Nazábal C; Viña L; Caballero E
    Dev Biol Stand; 1998; 92():269-76. PubMed ID: 9580372
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Marine gastropod hemocyanins as adjuvants of non-conjugated bacterial and viral proteins.
    Gesheva V; Idakieva K; Kerekov N; Nikolova K; Mihaylova N; Doumanova L; Tchorbanov A
    Fish Shellfish Immunol; 2011 Jan; 30(1):135-42. PubMed ID: 20887791
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Immune responses to pcDNA3.1 hisB-IL-15 and HBsAg DNA vaccine in BALB/c mice].
    Yang CY; Su XS; Li MN; He Y
    Zhonghua Gan Zang Bing Za Zhi; 2004 Dec; 12(12):758-9. PubMed ID: 15619350
    [No Abstract]   [Full Text] [Related]  

  • 48. Antibody responses in adult and neonatal BALB/c mice to immunization with novel Bordetella pertussis vaccine formulations.
    Gracia A; Polewicz M; Halperin SA; Hancock RE; Potter AA; Babiuk LA; Gerdts V
    Vaccine; 2011 Feb; 29(8):1595-604. PubMed ID: 21215343
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Vaccine adjuvant systems containing monophosphoryl lipid A and QS21 induce strong and persistent humoral and T cell responses against hepatitis B surface antigen in healthy adult volunteers.
    Vandepapelière P; Horsmans Y; Moris P; Van Mechelen M; Janssens M; Koutsoukos M; Van Belle P; Clement F; Hanon E; Wettendorff M; Garçon N; Leroux-Roels G
    Vaccine; 2008 Mar; 26(10):1375-86. PubMed ID: 18272264
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
    Desombere I; Willems A; Gijbels Y; Leroux-Roels G
    J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mucosal and systemic antibody responses against an acellular pertussis vaccine in mice after intranasal co-administration with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Taniguchi T; Kozuka S; Matano K; Maeyama J; Morokuma K; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 2003 Mar; 21(11-12):1165-73. PubMed ID: 12559794
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A universal T cell epitope-containing peptide from hepatitis B surface antigen can enhance antibody specific for HIV gp120.
    Greenstein JL; Schad VC; Goodwin WH; Brauer AB; Bollinger BK; Chin RD; Kuo MC
    J Immunol; 1992 Jun; 148(12):3970-7. PubMed ID: 1376346
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Modulation of the antigen presentation activity in foot and mouth disease virus (FMDV) vaccines by two adjuvants: avridine and a water soluble fraction of Mycobacterium sp.
    Wigdorovitz A; Zamorano P; Borca MV; Sadir AM
    Vaccine; 1998 Oct; 16(17):1627-32. PubMed ID: 9713938
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Impact of different adjuvants on immunogenicity of the HBV particle vaccine containing the S + preS1 fusion antigen in Balb/C mice].
    Chen H; Deng Y; Tan W; Wang W; Yin X; Guan J; Wang W; Ruan L
    Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):74-8. PubMed ID: 20353095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Derivation of vaccines from mimotopes. Immunologic properties of human hepatitis B virus surface antigen mimotopes displayed on filamentous phage.
    Meola A; Delmastro P; Monaci P; Luzzago A; Nicosia A; Felici F; Cortese R; Galfrè G
    J Immunol; 1995 Apr; 154(7):3162-72. PubMed ID: 7534789
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A human-derived protein SBP (HBsAg-binding protein) can bind to hepatitis B virus surface antigen (HBsAg) and enhance the immune response to hepatitis B virus (HBV) vaccine.
    Zhang C; Gong L; Chen Y; Wang X; Zhu S; Li D; Pang Y; Yin Y; Liu X; Zhu N
    Mol Immunol; 2013 Jan; 53(1-2):60-71. PubMed ID: 22809814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant.
    Rharbaoui F; Drabner B; Borsutzky S; Winckler U; Morr M; Ensoli B; Mühlradt PF; Guzmán CA
    Eur J Immunol; 2002 Oct; 32(10):2857-65. PubMed ID: 12355438
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antigenicity of polypeptides (poly-alpha-amino acids). XXIV. Immunogenicity of a synthetic polymer of glutamic acid, lysine, alanine and tyrosine (GLAT).
    Maurer PH; Pinchuck P; Gerulat BF
    Int Arch Allergy Appl Immunol; 1967; 32(2):164-73. PubMed ID: 4965708
    [No Abstract]   [Full Text] [Related]  

  • 59. Humoral immune responses in mice using gamma inulin preparations as adjuvants for hepatitis B vaccines.
    Leslie DE; Nicholson S; Dimitrakakis M; Johnston N; Gust ID
    Immunol Cell Biol; 1990 Apr; 68 ( Pt 2)():107-12. PubMed ID: 1696560
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Specific immune response to HBsAg is enhanced by beta-glucan oligosaccharide containing an alpha-(1-->3)-linked bond and biased towards M2/Th2.
    Dong SF; Chen JM; Zhang W; Sun SH; Wang J; Gu JX; Boraschi D; Qu D
    Int Immunopharmacol; 2007 Jun; 7(6):725-33. PubMed ID: 17466906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.